Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
The Lancet Respiratory Medicine
Published October 26, 2026
Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, rand...
October 27, 2026
Medspoke
Medspoke
Respiratory Medicine
Published October 26, 2026
00:00
--:--
Cutaneous adverse reactions following initiation of vanzacaftor/tezacaftor/deutivacaftor in CFTR-...
October 27, 2026
Share
Cutaneous adverse reactions following initiation of vanzacaftor/tezacaftor/deutivacaftor in CFTR-modulator-naïve subjects: a case series.
https://www.medspoke.co/channel_journal?id=740&tap_id=16397
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
CHEST
Published October 26, 2026
Clinical Phenotypes and Prognostic Heterogeneity of Mild-to-Moderate Chronic Obstructive Pulmonar...
October 27, 2026
Why are you reporting this TALK?
